Tetra Bio-Pharma Overview
- Founded
- 2007

- Status
- Public
- Employees
- 32

- Stock Symbol
- TBP

- Investments
- 7
- Share Price
- $0.15
- (As of Friday Closing)
Tetra Bio-Pharma General Information
Description
Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical programs aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The company with its subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals and Veterinary Products containing cannabinoids. Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.
Contact Information
- 2316 Saint Joseph Boulevard
- Suite 1600
- Orleans, Ontario K1C 1E8
- Canada
Tetra Bio-Pharma Timeline
Tetra Bio-Pharma Stock Performance
(As of Friday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$0.15 | $0.16 | $0.10 - $0.53 | $43.4M | 282M | 520K | -$0.07 |
Tetra Bio-Pharma Financials Summary
In Thousands, USD |
TTM 31-Aug-2020 | FY 2019 30-Nov-2019 | FY 2018 30-Nov-2018 | FY 2017 30-Nov-2017 |
---|---|---|---|---|
EV | 29,023 | 55,124 | 110,444 | 61,681 |
Revenue | 0 | 0 | 0 | 0 |
EBITDA | (13,481) | (10,762) | (6,165) | (5,132) |
Net Income | (14,427) | (11,494) | (5,867) | (4,777) |
Total Assets | 31,811 | 21,497 | 17,647 | 8,655 |
Total Debt | 0 | 0 | 0 |
Tetra Bio-Pharma Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Tetra Bio-Pharma‘s full profile, request access.
Request a free trialTetra Bio-Pharma Executive Team (20)
Tetra Bio-Pharma Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
00000 00000 | Self | Executive Chairman | 000 0000 |
00000 00000 | Tetra Bio-Pharma | Executive Chairman | 000 0000 |
00000 00000000 | Tetra Bio-Pharma | Chairman & Founder | 000 0000 |
0000 000000 | Self | Board Member | 000 0000 |
000 00000000000 00.0 | Tetra Bio-Pharma | Chief Executive Officer & Board Member | 000 0000 |
Tetra Bio-Pharma Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTetra Bio-Pharma Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore Tetra Bio-Pharma‘s full profile, request access.
Request a free trialTetra Bio-Pharma Investments & Acquisitions (7)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
000 000000000000 | 21-Aug-2019 | 00000 0000000 | Pharmaceuticals | 000 00000000000 00.0 | |
00000 000000 | 01-May-2019 | 000000000000000000 | 0000 | Drug Discovery | 000 00000000000 00.0 |
00000 0000000 (000 | 29-Apr-2019 | 00000 0000000 | Drug Delivery | 000 00000000000 00.0 | |
000000000 000000 | 19-Mar-2018 | 000000000 00000000 | 00.00 | Pharmaceuticals | 0000000 0000000 |
Holizen | 22-Jun-2016 | Merger/Acquisition | 00000 | Drug Discovery | 0000 00000 |
Tetra Bio-Pharma Subsidiaries (2)
Company Name | Industry | Location | Founded |
---|---|---|---|
Panag Pharma | Drug Discovery | Halifax, Canada | 2014 |
0000000 000000000 | Gold Mining | Ottawa, Canada | 0000 |
Tetra Bio-Pharma Exits (2)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000000 | 22-Jun-2016 | 000000000000000000 | 00000 | Completed |
|
Export Hydro | 06-Nov-2015 | Merger/Acquisition | 000 | Completed |